Hepatology International

医学 胃肠肝病学

  • 影响指数:9.02
  • 中科院分区:医学 2区 医学 2 区
  • 审稿周期:平均2月
  • 自引率:15.3%
  • 录取率:25.%
  • ISSN:2190-572X
  • 发刊频率:暂无数据
  • 年文章数:454
  • 国人占比:28.74%
  • 期刊网址:点击查看
  • 研究方向:肝癌;肝炎;放疗;手术
  • 期刊攻略
  • IF变化趋势
  • 期刊占比
  • 最新文章

期刊简介

3 BIOTECH杂志暂不明确行业,暂不明确子行业的级别不明杂志

收稿要求

暂无数据

建议

杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。

Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study.

DOI:10.1007/s12072-022-10358-z

发表时间:2022 Jun 24

作者:Hatanaka T;Kakizaki S;Hiraoka A;Tada T;Hirooka M;Kariyama K;Tani J;Atsukawa M;Takaguchi K;Itobayashi E;Fukunishi S;Tsuji K;Ishikawa T;Tajiri K;Ochi H;Yasuda S;Toyoda H;Ogawa C;Nishimura T;Shimada N;Kawata K;Kosaka H;Tanaka T;Ohama H;Nouso K;Morishita A;Tsutsui A;Nagano T;Itokawa N;Okubo T;Arai T;Imai M;Naganuma A;Koizumi Y;Nakamura S;Joko K;Kaibori M;Iijima H;Hiasa Y;Kumada T;Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan).

SARS-CoV-2 infection and liver involvement.

DOI:10.1007/s12072-022-10364-1

发表时间:2022 Jun 29

作者:Luo M;Ballester MP;Soffientini U;Jalan R;Mehta G

Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial.

DOI:10.1007/s12072-022-10366-z

发表时间:2022 Jun 29

作者:Santos LAA;Lima TB;de Carvalho Nunes HR;Qi X;Romeiro FG

Aspirin for patients after TIPS: an old dog with new tricks?

DOI:10.1007/s12072-022-10383-y

发表时间:2022 Jun 29

作者:Wang J;Liu D;Chen S;Qi X

A prognostic model of acute-on-chronic liver failure based on sarcopenia.

DOI:10.1007/s12072-022-10363-2

发表时间:2022 Jun 30

作者:Peng H;Zhang Q;Luo L;Lei S;Xiong T;Long L;Xiong Y;Zhang L;Zheng J;Luo X

公众号